Lawrence S. Bader
Lawrence S. Bader is experienced in representing individuals and corporations in a wide range of complex commercial litigation, white collar criminal defense and securities enforcement matters. He has represented clients in federal and state courts, at the trial and appellate level throughout the United States, as well as in arbitrations before NYSE and NASD panels.
Larry's white collar criminal defense and securities enforcement practice has been extremely varied, including defending corporations and individuals in matters involving the federal securities laws (disclosure issues, insider trading, stock manipulation, commodities fraud), bank fraud, antitrust violations (bid rigging and price fixing), arms export control violations and tax fraud. He has represented clients under investigation by various United States Attorney’s Offices, District Attorney's Offices, the Securities and Exchange Commission and the New York State Attorney General’s Office. Larry has also conducted numerous internal investigations for corporate clients and counseled individuals involved in such investigations.
Larry has extensive experience in securities litigation both civil and criminal. Often, those cases involve concurrent governmental investigations; however, Larry also defends companies and executives in complex civil litigation that is unrelated to any government investigation. Such representations include defense in class actions, derivative cases, and other complex matters, usually involving the securities and antitrust laws.
He has been involved in a significant number of high-profile civil, regulatory and criminal matters including the investigations of Marsh, Inc, The Bayou Fund, Adelphia Communications Corporation, Daiwa Bank, Iran-Contra arms shipments, Drexel Burnham Lambert, Princeton Newport Partners, Wedtech and others.
- Current and former officers and directors of the pharmaceutical company Merck & Co. (the former Merck and Schering-Plough) in connection with the litigation and settlement of derivative litigation arising from claims that the drug maker delayed disappointing results of a clinical drug trial.
- A former pharmaceutical executive who, after pleading guilty to making false statements to the Federal Trade Commission pertaining to a patent dispute was ordered, as part of his sentence, to write a book about his experience.
- An employee of a U.S. subsidiary of a foreign corporation in connection with an investigation by the Department of Justice’s Antitrust Division into an alleged international price-fixing conspiracy.
- Representation of one of the state's largest-volume foreclosure law firms, in connection with investigations the New York State Attorney General and the United States Attorney for the Southern District of New York alleging that the firm engaged in faulty foreclosure practices on behalf of its bank clients.
- A senior executive of an international insurance brokerage firm in a securities class action involving “contingent commissions.”
- A hedge fund manager in connection with a DOJ and SEC investigation.
- An analyst for a broker/dealer who was accused by the SEC of insider trading.
- The CEO of a broker/dealer in connection with a U.S. Attorney and SEC investigation of alleged improper trading activity.
- A broker/dealer accused of fraud in a NYSE arbitration lasting 71 hearing sessions.
- A stockbroker in a federal criminal stock manipulation case.
Larry has been recognized in Thomson Reuters' Super Lawyers.
Larry is a member of the New York City Bar Association (member of the Government Ethics Committee, past member of the Criminal Courts Committee), American Bar Association (Antitrust Law, Criminal Justice, and Litigation Sections), Federal Bar Council, New York Council of Defense Lawyers, National Association of Criminal Defense Lawyers, and the Securities Industry and Financial Markets Association (Compliance and Legal Division).
Larry is the author of "SEC Enforcement Data Analyses," a quarterly report examining SEC cases that is based on a detailed analysis of publicly available information. This report can be found here. He is also a regular contributor to The Insider Blog on Forbes.com.